House Appropriations Votes to Halt WISeR Program Funding
The House Appropriations Committee has voted to halt funding for the WISeR prior authorization pilot, designed to manage and reduce inappropriate Medicare spending. This amendment, passed by voice vote on June 9, prevents the Centers for Medicare & Medicaid Services (CMS) from using federal funds for WISeR and any similar programs that incorporate prior authorization into traditional Medicare.
The WISeR project, launched in January 2026, applies prior authorization mechanisms to fee-for-service Medicare in states such as New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. This pilot employs private contractors and advanced technology, such as artificial intelligence, to scrutinize medical services commonly associated with fraud or lack of clinical value. Providers must secure prior authorization, or their claims are subject to prepayment review, adding a procedural step for reimbursement.
The initiative targets wasteful spending within Medicare, which constitutes a significant portion of healthcare costs. In 2022 alone, $5.8 billion was estimated to have been allocated to low-value services. WISeR aims to reduce these expenses and enhance patient safety by using AI-driven assessments verified by licensed clinicians, aligning with evidence-based criteria.
Services particularly vulnerable to misuse are targeted by the pilot, while inpatient-only services, emergency care, and situations where delays might endanger patient health are exempt. Providers within the program's regions must adjust to the new process of submitting prior authorization requests or face claim reviews if they proceed without pre-authorization.
Although WISeR does not change how Medicare covers or pays for services, it introduces review processes that could impact approval timing. Participants might receive exemptions if they demonstrate compliance, reducing administrative demands and concentrating on riskier services. This encourages financial motivation among participants to minimize improper utilization and costs while enhancing review efficiency.
Despite the benefits of prior authorization for managing service use and expenses, its implementation in traditional Medicare faces scrutiny due to potential delays and administrative burdens. As the appropriations bill progresses through Congress, the vote highlights scrutiny on AI-driven utilization controls within Medicare’s model, marking potential changes in access.
WISeR remains operational, requiring provider compliance amid ongoing legislative discussions. Should this initiative lose funding, a significant disruption could occur unless a phased alternative is implemented.